HERZLIYA, Israel and CALGARY, Alberta, Sept. 15, 2025 /CNW/ -- Innocan Pharma Corporation (CNSX:INNO.CN) (FSE:IP4) (OTC-BB:INNPF) ("Innocan" or the "Company"), a pioneer in the pharmaceutical and biotechnology industries, is pleased to announce that its LPT-CBD poster presentation, delivered by Dr. Joseph V. Pergolizzi, Jr., MD, MBA, at the PAINWeek conference in Las Vegas, sparked genuine enthusiasm among conference participants.
Read more at newswire.caThis article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.